Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 68071-3695

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 68071-3695). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3695 3)

Emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg film-coated tablets label from NuCare Pharmaceuticals, Inc. The label shows prescription information including the NDC 68071-3695-3, tablet description as capsule shaped, white, debossed with 'L24' on one side, and storage instructions at controlled temperature 59-86°F. Manufacturer details and barcode are also visible.*

FDA Label Image

123 (Structure Emtricitabine)

Chemical structure of emtricitabine, one of the active ingredients in Emtricitabine and tenofovir disoproxil fumarate tablets. The diagram shows atoms and bonds representing the molecule's composition and arrangement.*

FDA Label Image

134 (Structure Tenofovir)

Chemical structure of emtricitabine and tenofovir disoproxil fumarate, showing molecular components and bonds of the active ingredients in this combination medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.